Melanomas that develop within the eye inhibit lymphocyte proliferation

International Journal of Cancer

Volumn 73, Issue 4, 1997, Pages 470-478

  Verbik, David J ^a,c   Murray, Timothy G ^b   Tran, Johan M ^a   Ksander, Bruce R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN SPECIFICITY; ARTICLE; CELL CONTACT; CELL MIGRATION; CELL PROLIFERATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MELANOMA; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; CELL DIVISION; EYE NEOPLASMS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; MELANOMA; ORGAN SPECIFICITY; SKIN NEOPLASMS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0031435093     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971114)73:4<470::AID-IJC3>3.0.CO;2-X     Document Type: Article

References (20)

1. ALEXANDER, M.A., BENNICELLI, J. and GUERRY, D., Detective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease. J. Immunol., 142, 4070-4078 (1989).
2. BOON, T., CEROTTINI, J.C., VAN DEN EYNDE, B., VAN DER BRUGGEN, P. and VAN PEL, A., Tumor antigens recognized by T lymphocytes. Ann. Rev. Immunol., 12, 337-365 (1994).
3. FOSSATI, G., TARAMELLI, D., BALSARI, A., BOGDANOVICH, G., ANDREAOLA, S. and PARMIANI, G., Primary but not metastatic human melanomas expressing DR antigen stimulate autologous lymphocytes. Int. J. Cancer, 33, 591-597 (1984).
4. GRIFFITH, T.S., BRUNNER, T., FLETCHER, S.M., GREEN, D.R. and FERGUSON, T.A., Fas ligand induced apoptosis as a mechanism of immune privilege. Science, 270, 1189-1192 (1995).
5. GUERRY, D., ALEXANDER, M.A., ELDER, D.E. and HERLYN, M.F., Interferon-γ regulates the T cell response to precursor nevi and biologically early melanoma. J. Immunol., 139, 305-312 (1987).
6. GUERRY, D., ALEXANDER, M.A. and HERLYN, M.F., HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes. J. clin. Invest., 73, 267-271 (1984).
7. HAHNE, M., RIMOLDI, D., SCHROTER, M., ROMERO, P., SCHREIER, M., FRENCH, L.E., SCHNEIDER, P., BORNAND, T., FONTANA, A., LIÉNARD, D., CEROTTINI, J.C. and TSCHOPP, J., Melanoma cell expression of Fas(Apo-1/CD 95) ligand: implications for tumor immune escape. Science. 274, 1363-1366 (1996).
8. HERLYN, M., BALADAN, G., BENNICELLI, J., GUERRY, D., HALABAN, R., HERLYN, D., ELDER, D.E., MAUL, G.G., STEPLEWSKI, Z. and NOWELL, P.C., Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J. nat. Cancer Inst., 74, 283-289 (1985).
9. HUCK, S.W., CORMIER, W.H. and BOUNDS, W.G., Reading statistics and research, p. 68, Harper and Row, New York (1974).
10. INGE, T.H., HOOVER, S.K., SUSSKIND, B.M., BARRETT, S.K. and BEAR, H.D., Inhibition of tumor-specific cytotoxic T-lymphocyte response by transforming growth factor beta 1. Cancer Res., 52, 1386-1392 (1992).
11. KORNSTEIN, M.J., BROOKS, J.S.J. and ELDER, D.E., Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi. Cancer Res., 43, 2749-2753 (1983).
12. KSANDER, B.R., RUBSAMEN, P., OLSEN, K., COUSINS, S. and STREILEIN, J.W., Studies of tumor-infiltrating lymphocytes from a choroidal melanoma. Invest. Ophthalmol. Vis. Sci., 32, 3198-3207 (1991).
13. PARMIANI, G., ANICHINI, A. and FOSSATI, A., Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy? J. nat. Cancer Inst., 82, 361-370 (1990).
14. RAJPAL, S., MOORE, R. and KARAKOUSIS, C.P., Survival in metastatic ocular melanoma. Cancer, 52, 334-336 (1983).
15. RODECK, U., BOSSLER, A., GRAEVEN, U., FOX, F.E., NOWELL, P.C., KNABBE, C. and KARI, C., Transforming growth factor B production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res., 54, 575-581 (1994).
16. SHIELDS, J.A., Introduction to melanocytic tumors of the uvea. In: Diagnosis and management of intraocular tumors, pp. 65-82, C.V. Mosby, St. Louis (1983).
17. TARAMELLI, D., FOSSATI, G., BALSARI, A., MAROLDA, R. and PARMIANI, G., The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells. Int. J. Cancer, 34, 797-806 (1984).
18. TARAMELLI, D., MAZZOCCHI, A., CLEMENTE, C., FOSSATI, G. and PARMIANI, G., Lack of suppressive activity of human primary melanoma cells on the activation of autologous lymphocytes. Cancer Immunol. Immunother., 26, 61-66 (1988).
19. TRAVERSARI, C., VAN DER BRUGGEN, P., LUESCHER, I.F., LURQUIN, C., CHOMEZ, P., VAN PEL, A., DE PLAEN, E., AMAR-COSTESEC, A. and BOON, T., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. exp. Med., 176, 1453-1457 (1992).
20. VAN PEL, A., VAN DER BRUGGEN, P., COULIE, P.G., BRICHARD, V.G., LÉTHE, B., VAN DEN EYNDE, B., UYTTENHOVE, C., RENAULD, J. and BOON, T., Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol. Rev., 145, 229-250 (1995).